Related Experiment Videos
Nifedipine tablets for systemic hypertension: a study using continuous ambulatory intraarterial recording
The American Journal of Cardiology
|May 1, 1983
Summary
Twice-daily nifedipine tablets effectively reduce blood pressure (BP) for 24 hours in patients with essential hypertension. This sustained effect, even during exercise, suggests its potential as an initial antihypertensive therapy.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Essential hypertension management requires consistent blood pressure (BP) control.
- Nifedipine is an established antihypertensive medication.
Purpose of the Study:
- To evaluate the 24-hour BP-lowering profile of a new nifedipine tablet formulation.
- To assess the efficacy of both once-daily and twice-daily nifedipine tablet regimens.
- To examine BP responses during exercise in patients with essential hypertension.
Main Methods:
- A study involving 17 ambulatory patients with essential hypertension.
- Continuous intra-arterial BP monitoring over 24 hours.
- Assessment of BP during isometric and dynamic exercise testing.
Main Results:
- Twice-daily nifedipine tablets significantly reduced BP throughout the day (p < 0.001).
- Sustained BP reduction was observed during both isometric and dynamic exercise.
- Once-daily dosing showed diminished efficacy in the later hours.
- Mild side effects like ankle edema and facial flushing were reported but did not lead to withdrawal.
Conclusions:
- Nifedipine tablets administered twice daily provide consistent 24-hour BP control in essential hypertension patients.
- The formulation is effective in lowering BP during exercise.
- Nifedipine tablets may be a valuable option for initial antihypertensive therapy.